Atlas Trials

Dapagliflozin in Patients With Critical Illness

Clinical trial NCT05558098 · COMPLETED

Trial details

NCT number
NCT05558098
Sponsor
Hospital Israelita Albert Einstein
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Critical IllnessSepsis
Start date
2022-11-01
Primary completion
2023-10-20
Enrollment
507

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.